Being reliant on foreign manufacturing of needed medicine is also making them more dangerous, which the FDA is not keeping up with. youtu.be/j7IcjeSwawY #Conservatives #conservativenews #Libertarian #MAGA #RepublicanParty #pharmacoeconomics

Ever felt confused about how pharmacoeconomics actually plays a role in real healthcare decisions? Let’s dive into the core concepts like QALY, ICER, and evidence-based strategies Use discount code: Seeba10 scape-society.org/courses/pharma 🔥 Don’t miss out! #Pharmacoeconomics #SCAPE

Learn how to applypharmacoeconomic tools in real-world practice! Join Pharmacoeconomics in Practice: QALY, ICER & Evidence-Based Decision-Making with Dr. Hana Alabdulkarim. Use the discount code: NoraAlotaibi10 🔗 scape-society.org/courses/pharma #Healthcare #Pharmacoeconomics

📢 Call for Papers! Submit your research to Pharmacoeconomics and Policy (P&P) – a premier journal offering ✨lightning-fast review, 🌍global reach, and 💸no APCs for a limited time! Topics: #HTA, #Pharmacoeconomics, #HealthPolicy, 📝 Submit now: editorialmanager.com/pharp/default2…

We are currently commissioning articles for an article collection titled "Health Economics in #Cancer Treatment and Care" If you're interested in submitting, get in touch👉 [email protected] #HEOR #healtheconomics #pharmacoeconomics

📣Editorial Sharing: Volume 86, Issue 6 🧾The Clinical and Economic Value of Follow-on Biologics: Biosimilars, Biobetters, and Bioparallels 👩‍🔬Ivo Abraham, Karen Michelle MacDonald 💡Full Text: magonlinelibrary.com/doi/full/10.12… #biobetter #biosimilar #pharmacoeconomics #Medicine

What will shape #pharmacoeconomics in 2026? Your expert opinion matters! Take our quick survey, share your perspective, and be in for a chance to win a $40 Amazon gift voucher. Click here for the survey 👉 bit.ly/3ZAiPP8 #HEOR #healtheconomics #medicaleconomics

📢 Your expert opinion on #pharmacoeconomics trends for 2026 matters! Complete our short survey to share your views, and be in for a chance to win a $40 Amazon gift voucher. Click the link to have your say 👉 bit.ly/3ZAiPP8 #HEOR #healtheconomics #medicaleconomics

#Pharmacoeconomics now plays a pivotal role in modernizing Chinas healthcare system, especially in optimizing medication pricing frameworks and insurance coverage discussions. Learn more: ow.ly/YswV50VQN4j

Out in @ERCSPjournal Pharmacists substitute controlled substance generics HALF as often as other meds - interviews reveal patient distrust & regulatory hurdles as key barriers. #Generics #ControlledSubstances #PharmacyPractice #Opioids #Pharmacoeconomics sciencedirect.com/science/articl…

keyboard_arrow_left Previous keyboard_arrow_right Next

Looking ahead to 2026: Which #pharmacoeconomics topics will have the most impact? Share your expertise in this discussion by completing our brief survey 👉 invt.io/1txbq6unbf0 The results will be shared in an upcoming article in T&F's health economics journals. #HEOR

🔬 Is TDM1 cost-effective for HER-2+ breast cancer in Iran? A new study shows TDM1 adds +1.59 QALYs vs. trastuzumab at an extra \$1,408. 🇮🇷 ICER: \$886/QALY → below Iran’s threshold (\$1,085). Despite higher costs, TDM1 is cost-effective. #BreastCancer #Pharmacoeconomics #TDM1

📌 ISPOR names RWE the top trend in HEOR, signaling its rising impact on healthcare decisions. 👉 The BCMAS® program offers in-depth HEOR training to help you lead with value: hubs.ly/Q03mNb5k0 #HEOR #RealWorldEvidence #BCMAS #MedicalAffairs #Pharmacoeconomics

Our Executive Editor will be attending ISPOR Annual in Montreal. Reach out if you are attending too and would like to connect! #ispor2025 #ispor #heor #healtheconomics #outcomesresearch #healthpolicy #medicaleconomics #pharmacoeconomics

Attending #ASX25 this week? If so, drop by exhibit booth 1533 to discuss the latest in Market Access, HEOR, pharmacoeconomics, and more with our on-site experts. Learn more at buff.ly/Yjoazu4 #ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia

💉 State could face a €10bn annual drug bill if weight loss jabs like Mounjaro and Wegovy are funded for all eligible. Current bill sits at €4bn. Big decisions ahead on who qualifies. #AI #VirtualsProtocol #Healthcare #Obesity #Pharmacoeconomics

Attending next week's #ASX25? If so, plan to stop by exhibit booth 1533 to discuss the latest in Market Access, HEOR, pharmacoeconomics, and more with our on-site experts. Learn more at buff.ly/I1W9gn9 #ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia

#Ireland's liraglutide program shows how to balance: 💊 Patient needs 📊 Cost-effectiveness 💰 Budget impact Only 52% met strict Health Tech Assessment criteria #HealthPolicy #Obesity #ObesityMedicine #Liraglutide #Diabetes #Pharmacoeconomics #Pharmacy 🔗sciencedirect.com/science/articl…

Seen this way too often during fellowship days. Families are drained of life savings, ancestral lands are sold, children leave colleges to start jobs. Equitable cancer care needs a renewed redressal in LMICs. More conversations need to happen. #CancerTreatment #pharmacoeconomics

Ishwaria Subbiah, MD MS FASCO @IshwariaMD

3 years ago

Seen this way too often during fellowship days. Families are drained of life savings, ancestral lands are sold, children leave colleges to start jobs. Equitable cancer care needs a renewed redressal in LMICs. More conversations need to happen. #CancerTreatment #pharmacoeconomics

4 172 403 0 38

Download Image

Early metformin for gestational diabetes?🤰💊 A slight bump in cost, a tiny QALY gain, early metformin for GDM shows no strong cost-effectiveness in EMERGE trial findings. #PharmacoEconomics #Diabetes #GestationalDiabetes #Metformin #HealthEconomics onlinelibrary.wiley.com/doi/10.1111/dm…